Prenetics Execs to Present at ROTH Conference Amid Rapid IM8 Growth
Event summary
- Prenetics CEO Danny Yeung and President of Americas David Vanderveen to participate in 38th Annual ROTH Conference (March 22-24, 2026).
- Company to host fireside chat and consumer influencer panel on March 23, 2026.
- IM8 brand achieved $100M in annualized recurring revenue within 11 months of launch.
- IM8 products now sold in over 30 countries worldwide.
The big picture
Prenetics' participation in the ROTH Conference comes as its IM8 brand demonstrates explosive growth in the premium consumer health sector. The company is positioning itself as a leader in the longevity market through high-profile partnerships and rapid international expansion. The conference presentations will be key indicators of how Prenetics plans to maintain its momentum in a space increasingly dominated by both traditional supplement companies and tech-driven health startups.
What we're watching
- Brand Momentum
- Whether IM8 can sustain its rapid revenue growth trajectory in an increasingly competitive premium nutrition market.
- Strategic Positioning
- How Prenetics will leverage celebrity partnerships to expand its global footprint beyond current 30-country distribution.
- Investor Sentiment
- The impact of conference presentations on investor perception of Prenetics' valuation and growth prospects.
Related topics